Market Overview

Anima Biotech to Present at the 13th Annual European Life Sciences CEO Forum

Share:

BERNARDSVILLE, N.J., Feb. 17, 2020 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule drugs that control mRNA translation, today announced the company will present at the 13th Annual European Life Sciences CEO Forum, taking place in Zurich, Switzerland, Feb. 19 – 20, 2020.

Yochi Slonim, Co-founder and Chief Executive Officer of Anima Biotech, will provide an overview of the company's business, technology and partnering activities and will be available for questions and one-on-one meetings with attendees registered for the conference.

Additionally, Mr. Slonim will participate on a "Platform Technologies & Novel Therapeutics" panel during the meeting.

Details regarding the company's presentation are as follows:

Event: 13th Annual European Life Sciences CEO Forum
Date: Wednesday, Feb. 19, 2020
Time: 12:25 p.m. CET
Room: Berne (Track A)
Venue: Hilton Zurich Airport Hotel, Zurich, Switzerland

Details regarding the panel discussion are as follows:

Date: Wednesday, Feb. 19, 2020
Time: 5:15 p.m. CET
Room: Panorama

About Anima Biotech

Anima Biotech is advancing its Translation Control Platform, the first and only platform for the discovery of small molecule drugs that control mRNA translation as a new strategy against many diseases. With novel biology that monitors the translation of proteins and proprietary cloud-based analysis software, we identify drug candidates that modulate a target protein's production. We develop a pipeline across therapeutic areas and partner with Pharma for their targets including our $1B+ collaboration with Lilly for the discovery and development of translation inhibitors of several targets. Our approach was further validated with 5 granted patents, 14 peer reviewed publications and 17 scientific collaborations. To learn more about us, visit https://www.animabiotech.com

Media Contact:
Andrew Mielach
LifeSci Communications
+1.646.876.5868
amielach@lifescicommunications.com

Primary Logo

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com